Technical Specifications Compound: Synthetic Tri-Agonist Peptide (Retatrutide) Format: Lyophilized research peptide kit Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Included: Multiple vials (exact count based on your kit contents) Intended Use This kit is designed exclusively for: Laboratory research In-vitro experimentation Biochemical pathway modeling Peptide-receptor interaction studies Non-human preclinical research Academic and institutional scientific work Not intended for: Human or animal use Injection, ingestion, inhalation, or topical administration Medical, therapeutic, diagnostic, or health-related purposes This compound is not approved by Health Canada, FDA, or any regulatory body for clinical application
Some people think "close enough" is fine
Constipation: common but manageable Constipation is frequently reported with GLP-1 therapy and may worsen with: Low fibre intake Reduced food intake Inadequate hydration A sedentary lifestyle Helpful measures may include: Adequate water intake Fibre-rich fruits and vegetables Walking or light physical activity Isabgol or fibre supplementation if medically appropriate To reduce nausea, many patients find relief by switching to lighter regional Indian meals and smaller portions during the first few weeks
Movement is part of the conversation from your first visit
doi: 10.1111/obr.70079
Suppresses glucagon when appropriate
